Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands

Cannabis has been used as a medicinal and natural product for thousands of years. Whether it has been used to make rope or paper, or been used to treat pain or depression, cannabis has always had a place in human civilisation. With the isolation of the psychoactive compounds responsible for cannab...

Full description

Bibliographic Details
Main Author: Holt, Christopher James
Format: Thesis (University of Nottingham only)
Language:English
Published: 2009
Online Access:https://eprints.nottingham.ac.uk/10712/
_version_ 1848791120271638528
author Holt, Christopher James
author_facet Holt, Christopher James
author_sort Holt, Christopher James
building Nottingham Research Data Repository
collection Online Access
description Cannabis has been used as a medicinal and natural product for thousands of years. Whether it has been used to make rope or paper, or been used to treat pain or depression, cannabis has always had a place in human civilisation. With the isolation of the psychoactive compounds responsible for cannabis’ effects, the discovery of two human cannabinoid receptors and an expanding knowledge of the therapeutic uses of cannabis, interest in the development of novel cannabinoids grew. The CB2 cannabinoid receptor has gained particular attention, as the often unwanted central and psychoactive effects of cannabinoids has been attributed to the CB1 cannabinoid receptor. Development of CB2 receptor selective ligands offers treatment opportunities in many areas, but most especially for pain, multiple sclerosis and immunomodulation. The preparation of fluorescently labelled ligands for a variety of receptors has improved compound screening techniques, as well as allowing use as biomolecular probes for aiding our understanding of the receptor in situ. The aim of this work is to design, synthesise and evaluate novel fluorescently labelled cannabinoids, with a particular interest in CB2 selective compounds. Focusing on the CB2 receptor selective alkylindole JWH-015, targeted substitutions were made to its naphthyl ring to identify sites that might be suitable for fluorophore attachment. With a site chosen, a series of fluorescent JWH-015 analogues was synthesised and evaluated for their CB2 receptor binding affinities. Though none of the evaluated compounds showed sufficient binding affinity for them to be used as biomolecular tools, the structure activity relationships gained suggested that improved design of fluorescent JWH-015 analogues in future could lead to the first ever active fluorescent cannabinoid.
first_indexed 2025-11-14T18:23:27Z
format Thesis (University of Nottingham only)
id nottingham-10712
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:23:27Z
publishDate 2009
recordtype eprints
repository_type Digital Repository
spelling nottingham-107122025-02-28T11:09:21Z https://eprints.nottingham.ac.uk/10712/ Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands Holt, Christopher James Cannabis has been used as a medicinal and natural product for thousands of years. Whether it has been used to make rope or paper, or been used to treat pain or depression, cannabis has always had a place in human civilisation. With the isolation of the psychoactive compounds responsible for cannabis’ effects, the discovery of two human cannabinoid receptors and an expanding knowledge of the therapeutic uses of cannabis, interest in the development of novel cannabinoids grew. The CB2 cannabinoid receptor has gained particular attention, as the often unwanted central and psychoactive effects of cannabinoids has been attributed to the CB1 cannabinoid receptor. Development of CB2 receptor selective ligands offers treatment opportunities in many areas, but most especially for pain, multiple sclerosis and immunomodulation. The preparation of fluorescently labelled ligands for a variety of receptors has improved compound screening techniques, as well as allowing use as biomolecular probes for aiding our understanding of the receptor in situ. The aim of this work is to design, synthesise and evaluate novel fluorescently labelled cannabinoids, with a particular interest in CB2 selective compounds. Focusing on the CB2 receptor selective alkylindole JWH-015, targeted substitutions were made to its naphthyl ring to identify sites that might be suitable for fluorophore attachment. With a site chosen, a series of fluorescent JWH-015 analogues was synthesised and evaluated for their CB2 receptor binding affinities. Though none of the evaluated compounds showed sufficient binding affinity for them to be used as biomolecular tools, the structure activity relationships gained suggested that improved design of fluorescent JWH-015 analogues in future could lead to the first ever active fluorescent cannabinoid. 2009-07-23 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/10712/1/Chris_Holt_PhD.pdf Holt, Christopher James (2009) Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands. PhD thesis, University of Nottingham.
spellingShingle Holt, Christopher James
Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title_full Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title_fullStr Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title_full_unstemmed Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title_short Design, synthesis and evaluation of fluorescent CB2 cannabinoid receptor ligands
title_sort design, synthesis and evaluation of fluorescent cb2 cannabinoid receptor ligands
url https://eprints.nottingham.ac.uk/10712/